Catalina Capital Group LLC Boosts Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Catalina Capital Group LLC lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 31.3% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,401 shares of the medical equipment provider’s stock after buying an additional 573 shares during the period. Catalina Capital Group LLC’s holdings in Intuitive Surgical were worth $958,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. TFB Advisors LLC acquired a new position in shares of Intuitive Surgical in the 1st quarter valued at $514,000. Mediolanum International Funds Ltd acquired a new position in Intuitive Surgical in the first quarter valued at $17,154,000. Callan Capital LLC purchased a new stake in shares of Intuitive Surgical in the first quarter valued at about $236,000. MRA Advisory Group boosted its stake in shares of Intuitive Surgical by 126.8% during the first quarter. MRA Advisory Group now owns 1,692 shares of the medical equipment provider’s stock worth $675,000 after buying an additional 946 shares during the period. Finally, Rehmann Capital Advisory Group grew its holdings in shares of Intuitive Surgical by 4.3% during the first quarter. Rehmann Capital Advisory Group now owns 1,753 shares of the medical equipment provider’s stock worth $700,000 after buying an additional 73 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 0.6 %

Shares of NASDAQ:ISRG traded up $2.44 on Wednesday, hitting $444.74. The company had a trading volume of 1,082,542 shares, compared to its average volume of 1,506,112. The company has a market cap of $157.75 billion, a PE ratio of 79.84, a PEG ratio of 5.74 and a beta of 1.39. The business has a 50 day moving average of $413.05 and a 200 day moving average of $388.89. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $448.10.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The business had revenue of $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. During the same period in the previous year, the firm posted $1.00 earnings per share. The company’s quarterly revenue was up 11.5% compared to the same quarter last year. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 4.8 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have commented on ISRG. Robert W. Baird decreased their price objective on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a research report on Friday, April 19th. BTIG Research lifted their price objective on shares of Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research report on Friday, April 19th. The Goldman Sachs Group started coverage on shares of Intuitive Surgical in a research note on Thursday, May 30th. They issued a “buy” rating and a $500.00 price objective on the stock. Stifel Nicolaus lifted their target price on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a report on Monday, April 8th. Finally, Citigroup increased their price target on shares of Intuitive Surgical from $462.00 to $512.00 and gave the stock a “buy” rating in a report on Wednesday. Six equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $410.32.

Insider Transactions at Intuitive Surgical

In other news, EVP Myriam Curet sold 5,318 shares of the company’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the completion of the transaction, the executive vice president now owns 298 shares of the company’s stock, valued at approximately $110,456.68. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, Director Alan J. Levy sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the transaction, the director now directly owns 25,319 shares in the company, valued at approximately $9,385,753.30. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Myriam Curet sold 5,318 shares of the firm’s stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the completion of the transaction, the executive vice president now owns 298 shares in the company, valued at approximately $110,456.68. The disclosure for this sale can be found here. Insiders have sold 17,956 shares of company stock worth $6,927,011 over the last quarter. 0.80% of the stock is currently owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.